Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Yole Group Market Research, deeptech | Other 31 Jul 2023 | | ||
ENPICOM biotech, deeptech, Biotechnology Research | Other 30 Nov 2023 | | ||
Genome Medical healthtech, Hospitals and Health Care | Other 16 Jul 2023 | | ||
BioVoice News Newspaper Publishing | Other 18 Jul 2023 | | ||
PharmaBoardroom Pharmaceutical Manufacturing | Other 1 Jul 2023 | | ||
Projective Group fintech, Financial Services | Other 2 Jul 2023 | | ||
RARE Revolution Magazine Media Production | Other 10 Jun 2023 | | ||
Diversigen, Inc. biotech, deeptech, Biotechnology Research | Other 15 Jun 2023 | | ||
EUCOPE - European Confederation of Pharmaceutical Entrepreneurs biotech, deeptech, healthtech, Non-profit Organizations | Other 19 Jun 2023 | | ||
Fondation Mérieux healthtech, Non-profit Organizations | Other 7 Nov 2023 | |